Update: 08.10.2024
Last week: 39 week 2024 (23.09.2024 - 29.09.2024)
Last full month: August 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 9 188 | 3.4% | 13.7% | 0.5 | 16 406 621 | 1.9% | 9.3% | 0.2 | -0.2% |
| MoM | 35 261 | 5.1% | 13.5% | 0.3 | 65 816 842 | 1.7% | 9.5% | -0.1 | 2.4% |
| YTD | 291 043 | 22.5% | 11.9% | 3.1 | 606 369 516 | 36.4% | 9.4% | 2 | -9.0% |
| MAT | 394 264 | 25.7% | 11.3% | 2.5 | 818 718 777 | 40.9% | 9.1% | 1.8 | -2.3% |
| BRAINMAX | |||||||||
| WoW | 1 941 | 15.1% | 100.0% | 0 | 6 661 796 | 12.6% | 100.0% | 0 | 15.1% |
| MoM | 6 855 | 12.4% | 100.0% | 0 | 24 503 753 | 13.7% | 100.0% | 0 | 12.4% |
| YTD | 49 229 | 60.1% | 100.0% | 0 | 173 685 654 | 65.7% | 100.0% | 0 | 60.1% |
| MAT | 65 130 | 69.8% | 100.0% | 0 | 229 875 306 | 78.1% | 100.0% | 0 | 69.8% |
| GOLDLINE PLUS | |||||||||
| WoW | 14 456 | 0.5% | 46.9% | 0.9 | 44 943 063 | 1.1% | 38.7% | 1.1 | -1.5% |
| MoM | 65 862 | -3.2% | 45.6% | -0.7 | 204 367 766 | -3.8% | 37.6% | -0.6 | -1.6% |
| YTD | 641 775 | -5.1% | 45.1% | 0.5 | 2 017 275 708 | -2.8% | 36.9% | -2.8 | -6.1% |
| MAT | 834 809 | -0.7% | 45.3% | 0.5 | 2 634 479 202 | 3.4% | 37.5% | -2.3 | -1.9% |
| MIGRENIUM | |||||||||
| WoW | 9 565 | -2.6% | 0.4% | 0 | 3 221 524 | -2.5% | 0.6% | 0 | -3.4% |
| MoM | 52 363 | 14.4% | 0.5% | 0 | 17 438 969 | 13.0% | 0.7% | 0 | 5.1% |
| YTD | 449 531 | -9.8% | 0.5% | -0.1 | 140 994 391 | 53.9% | 0.7% | 0.2 | 6.7% |
| MAT | 592 817 | -9.6% | 0.5% | -0.1 | 172 068 927 | 43.1% | 0.6% | 0.1 | 10.6% |
| MODELAX-N | |||||||||
| WoW | 25 648 | 0.3% | 21.0% | 0.4 | 12 239 184 | 0.7% | 13.9% | 0.3 | -1.8% |
| MoM | 107 491 | 4.4% | 19.5% | 0.2 | 50 399 196 | 4.7% | 12.9% | -0.1 | 3.5% |
| YTD | 1 109 990 | 30.5% | 22.4% | 3.7 | 485 079 753 | 79.9% | 14.5% | 4.1 | 9.2% |
| MAT | 1 427 420 | 42.4% | 21.3% | 4.2 | 598 270 949 | 86.4% | 13.4% | 3.8 | 14.6% |
| REDUXIN | |||||||||
| WoW | 9 841 | -2.8% | 32.0% | -0.4 | 50 512 662 | -3.8% | 43.5% | -0.9 | -1.5% |
| MoM | 47 269 | -1.9% | 32.8% | -0.1 | 241 692 826 | -2.4% | 44.5% | -0.1 | -1.6% |
| YTD | 467 427 | -7.8% | 32.8% | -0.6 | 2 486 921 095 | 12.3% | 45.5% | 3.1 | -6.1% |
| MAT | 598 530 | -4.9% | 32.5% | -1 | 3 145 172 524 | 16.2% | 44.8% | 2.5 | -1.9% |
| REDUXIN FORTE | |||||||||
| WoW | 2 957 | -7.4% | 9.6% | -0.6 | 12 704 769 | -4.2% | 10.9% | -0.3 | -1.5% |
| MoM | 13 962 | 2.0% | 9.7% | 0.3 | 58 566 373 | 1.0% | 10.8% | 0.3 | -1.6% |
| YTD | 128 272 | 1.0% | 9.0% | 0.6 | 553 164 999 | 12.8% | 10.1% | 0.7 | -6.1% |
| MAT | 167 274 | 7.4% | 9.1% | 0.8 | 716 173 948 | 19.2% | 10.2% | 0.8 | -1.9% |
| SALVISAR | |||||||||
| WoW | 11 250 | -0.2% | 1.5% | 0.1 | 4 818 691 | -0.0% | 1.3% | 0.1 | -4.4% |
| MoM | 39 431 | 12.9% | 1.2% | 0.1 | 16 898 831 | 7.9% | 1.1% | 0 | 7.0% |
| YTD | 392 081 | 4.6% | 1.4% | 0.1 | 161 063 451 | 30.8% | 1.2% | 0.1 | -2.2% |
| MAT | 515 486 | -6.1% | 1.3% | -0.1 | 201 670 729 | 9.8% | 1.1% | -0.1 | 2.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 291 043 | 22.5% | 11.9% | 3.1 | 606 369 516 | 36.4% | 9.4% | 2 | -9.0% |
| BRAINMAX | 49 229 | 60.1% | 100.0% | 0 | 173 685 654 | 65.7% | 100.0% | 0 | 60.1% |
| GOLDLINE PLUS | 641 775 | -5.1% | 45.1% | 0.5 | 2 017 275 708 | -2.8% | 36.9% | -2.8 | -6.1% |
| MIGRENIUM | 449 531 | -9.8% | 0.5% | -0.1 | 140 994 391 | 53.9% | 0.7% | 0.2 | 6.7% |
| MODELAX-N | 1 109 990 | 30.5% | 22.4% | 3.7 | 485 079 753 | 79.9% | 14.5% | 4.1 | 9.2% |
| REDUXIN CAPS | 467 427 | -7.8% | 32.8% | -0.6 | 2 486 921 095 | 12.3% | 45.5% | 3.1 | -6.1% |
| REDUXIN FORTE | 128 272 | 1.0% | 9.0% | 0.6 | 553 164 999 | 12.8% | 10.1% | 0.7 | -6.1% |
| SALVISAR | 392 081 | 4.6% | 1.4% | 0.1 | 161 063 451 | 30.8% | 1.2% | 0.1 | -2.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 394 264 | 25.7% | 11.3% | 2.5 | 818 718 777 | 40.9% | 9.1% | 1.8 | -2.3% |
| BRAINMAX | 65 130 | 69.8% | 100.0% | 0 | 229 875 306 | 78.1% | 100.0% | 0 | 69.8% |
| GOLDLINE PLUS | 834 809 | -0.7% | 45.3% | 0.5 | 2 634 479 202 | 3.4% | 37.5% | -2.3 | -1.9% |
| MIGRENIUM | 592 817 | -9.6% | 0.5% | -0.1 | 172 068 927 | 43.1% | 0.6% | 0.1 | 10.6% |
| MODELAX-N | 1 427 420 | 42.4% | 21.3% | 4.2 | 598 270 949 | 86.4% | 13.4% | 3.8 | 14.6% |
| REDUXIN CAPS | 598 530 | -4.9% | 32.5% | -1 | 3 145 172 524 | 16.2% | 44.8% | 2.5 | -1.9% |
| REDUXIN FORTE | 167 274 | 7.4% | 9.1% | 0.8 | 716 173 948 | 19.2% | 10.2% | 0.8 | -1.9% |
| SALVISAR | 515 486 | -6.1% | 1.3% | -0.1 | 201 670 729 | 9.8% | 1.1% | -0.1 | 2.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 9 188 | 3.4% | 13.7% | 0.5 | 16 406 621 | 1.9% | 9.3% | 0.2 | -0.2% |
| BRAINMAX | 1 941 | 15.1% | 100.0% | 0 | 6 661 796 | 12.6% | 100.0% | 0 | 15.1% |
| GOLDLINE PLUS | 14 456 | 0.5% | 46.9% | 0.9 | 44 943 063 | 1.1% | 38.7% | 1.1 | -1.5% |
| MIGRENIUM | 9 565 | -2.6% | 0.4% | 0 | 3 221 524 | -2.5% | 0.6% | 0 | -3.4% |
| MODELAX-N | 25 648 | 0.3% | 21.0% | 0.4 | 12 239 184 | 0.7% | 13.9% | 0.3 | -1.8% |
| REDUXIN CAPS | 9 841 | -2.8% | 32.0% | -0.4 | 50 512 662 | -3.8% | 43.5% | -0.9 | -1.5% |
| REDUXIN FORTE | 2 957 | -7.4% | 9.6% | -0.6 | 12 704 769 | -4.2% | 10.9% | -0.3 | -1.5% |
| SALVISAR | 11 250 | -0.2% | 1.5% | 0.1 | 4 818 691 | -0.0% | 1.3% | 0.1 | -4.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 35 261 | 5.1% | 13.5% | 0.3 | 65 816 842 | 1.7% | 9.5% | -0.1 | 2.4% |
| BRAINMAX | 6 855 | 12.4% | 100.0% | 0 | 24 503 753 | 13.7% | 100.0% | 0 | 12.4% |
| GOLDLINE PLUS | 65 862 | -3.2% | 45.6% | -0.7 | 204 367 766 | -3.8% | 37.6% | -0.6 | -1.6% |
| MIGRENIUM | 52 363 | 14.4% | 0.5% | 0 | 17 438 969 | 13.0% | 0.7% | 0 | 5.1% |
| MODELAX-N | 107 491 | 4.4% | 19.5% | 0.2 | 50 399 196 | 4.7% | 12.9% | -0.1 | 3.5% |
| REDUXIN CAPS | 47 269 | -1.9% | 32.8% | -0.1 | 241 692 826 | -2.4% | 44.5% | -0.1 | -1.6% |
| REDUXIN FORTE | 13 962 | 2.0% | 9.7% | 0.3 | 58 566 373 | 1.0% | 10.8% | 0.3 | -1.6% |
| SALVISAR | 39 431 | 12.9% | 1.2% | 0.1 | 16 898 831 | 7.9% | 1.1% | 0 | 7.0% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs